AMNEAL PHARMACEUTICALS for AMNEAL PHARMACEUTICALS
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Addressing drug shortages and enhancing domestic production of critical medicines Issues and proposed legislation related to long-term sustainability of access for patients to generic and biosimilar medicines, including but not limited to pharmaceutical supply chain security, drug shortages, biosimilar interchangeability, and PBM reform Issues related to Medicaid Generics Penalty Issues related to possible drug shortage of levothyroxine capsules Issues related to tariffs Appropriations for increasing domestic manufacturing of generic medicines Issues related to NDAA
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIAN MALASI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.